Sigma-Aldrich 2 3-BUTANEDIONE OXIME

Name: Sigma-Aldrich 2 3-BUTANEDIONE OXIME
SKU: SIALMSD-31550-25G
Price: 80.52 USD

List Price $80.52 Your Price $80.52

Sigma-Aldrich 2,3-Butanedione monoxime, for spectrophotometric det. of urea, ≥99.0%, 25 g - SIALMSD (Additional S&H or Hazmat Fees May Apply)

NETA PART: SIALMSD-31550-25G

MFG.PART: 31550-25G

UNSPSC: 41116105

Manufacturer: Sigma-Aldrich

Description

Quality Level
100

assay
≥98.0% (N) ≥99.0%

form
solid

quality
for spectrophotometric det. of urea

technique(s)
UV/Vis spectroscopy: suitable

ign. residue
≤0.05% (as SO₄)

bp
185-186 °C (lit.)

mp
75-76 °C 75-78 °C (lit.)

SMILES string
CC(=O)\C(C)=N\O

InChI
1S/C4H7NO2/c1-3(5-7)4(2)6/h7H,1-2H3/b5-3+

General description

A novel method to extend viability and functionality of living heart slices.: This research introduces a novel application of 2,3-Butanedione monoxime for prolonging the functional lifespan of cardiac tissue samples in experimental settings, offering insights into cardiac biology and potential therapeutic targets (Ross et al., 2023).

Molecular Mechanisms of Deregulation of Muscle Contractility Caused by the R168H Mutation in TPM3 and Its Attenuation by Therapeutic Agents.: The study utilizes 2,3-Butanedione monoxime to investigate the molecular pathways affected by genetic mutations in muscle contractility, contributing to the understanding of muscle disorders and their management (Karpicheva et al., 2023).

Generation of myocyte agonal Ca(2+) waves and contraction bands in perfused rat hearts following irreversible membrane permeabilisation.: Research employing 2,3-Butanedione monoxime investigates its role in inducing specific cellular events in cardiac cells under stress, highlighting its potential in studies of heart disease mechanisms and therapies (Morishita et al., 2023).

A novel method to extend viability and functionality of living heart slices.
Molecular Mechanisms of Deregulation of Muscle Contractility Caused by the R168H Mutation in TPM3 and Its Attenuation by Therapeutic Agents.: The study utilizes 2,3-Butanedione monoxime to investigate the molecular pathways affected by genetic mutations in muscle contractility, contributing to the understanding of muscle disorders and their management (Karpicheva et al., 2023).

Analysis Note
Other Notes Reagent for the colorimetric determination of urea and ureido-compounds; Spectrometric reagent for Co(II), Ni(II), Pd(II) and Re(VII); Reagent for the gravimetric determination of Ni(II)

Specifications